Comparison of BTD and BCD Based Regimens in the Treatment of AL Amyloidosis

NCT04612582 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Immunoglobulin Light-Chain Amyloidosis

Interventions

DRUG: Thalidomide
DRUG: Cyclophosphamide

Sponsor

Guangdong Provincial People's Hospital